Código QR (código de barras bidimensional)

BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer

Background: While the triplet combination of encorafenib (ENCO), binimetinib (BINI), plus cetuximab (CET) yielded a higher response rate compared with the doublet combination of ENCO plus CET, no significant survival benefits of the triplet combination were observed in patients with BRAF V600E-mutan...

Fuld beskrivelse

Na minha lista:
Principais autores: Y. Matsubara, H. Bando, D. Kotani, Y. Kagawa, K. Harada, H. Osumi, N. Izawa, T. Kawakami, S. Boku, T. Matsumoto, M. Wakabayashi, T. Yoshino
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2024-06-01
Serier:ESMO Gastrointestinal Oncology
Fag:
BRAF V600E
metastatic colorectal cancer
encorafenib
binimetinib
cetuximab
Online adgang:http://www.sciencedirect.com/science/article/pii/S294981982400027X
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker